VYGR NASDAQ
Voyager Therapeutics, Inc.
1W: -4.5%
1M: -15.3%
3M: -31.4%
YTD: -14.9%
1Y: -3.1%
3Y: -69.8%
5Y: -19.3%
$3.43
+0.06 (+1.78%)
Pre-Market: $3.37 (-0.06, -1.90%)
Weekly Expected Move ±9.0%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$36M
Revenue
-45.5% YoY
$-117M
Net Income
-37.7% YoY
$-130M
Free Cash Flow
-14.0% YoY
64.1%
Gross Margin
-1167.4%
Op. Margin
-1077.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-47.0%
ROA-36.1%
ROIC-278.6%
Valuation
P/E-1.7
P/B1.2
EV/EBITDA-0.6
Leverage
Debt/Equity0.19
Current Ratio7.64
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z-0.67
Beneish M-3.24